• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

W.L. Gore & Associates

Gore touts first use of Tag conformable thoracic stent graft in Australia

July 3, 2018 By Fink Densford

W.L. Gore & Associates said yesterday that it launched its Gore Tag conformable thoracic stent graft with active control in Australia, touting that the first procedures with the device have been performed in the region. The first implant procedures with the device were performed by Dr. Ian Spark of Adelaide, Australia’s Flinders Medical Centre, Gore said. […]

Filed Under: Business/Financial News, Stent Grafts, Vascular Tagged With: W.L. Gore & Associates

Gore wins expanded indications for Cardioform septal occluder

April 3, 2018 By Fink Densford

W.L. Gore & Associates said today it won expanded FDA indications for its Cardioform septal occluder, now cleared for the closure of patent foramen ovale to reduce the risk of recurrent ischemic stroke in certain patients. The expanded application was supported by results from the Reduce study, which the Newark, Del.-based company said showed that […]

Filed Under: Cardiovascular, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: W.L. Gore & Associates

Gore launches FDA IDE Excluder conformable AAA endoprosthesis trial

January 3, 2018 By Fink Densford

W.L. Gore & Associates today announced the first implant of its Gore Excluder conformable abdominal aortic aneurysm endoprosthesis in the US as part of an FDA-approved investigational clinical study. The procedure was performed on December 19 at New York’s Maimonides Medical Center by national principal investigator Dr. Robert Rhee. “Patients with extreme proximal neck anatomies often […]

Filed Under: Clinical Trials, Vascular Tagged With: W.L. Gore & Associates

Gore launches anti-migration assurance program for Viabil stent

October 4, 2017 By Fink Densford

W.L. Gore & Associates said today it launched an Anti-Migration Assurance Program for its Viabil short wire biliary endoprosthesis through which it will provide replacement devices for patients whose device moves out of place within a year of implantation. The Flagstaff, Ariz.-based company said the short wire biliary endoprosthesis has an average migration rate of 0.2%, […]

Filed Under: Business/Financial News, Stents Tagged With: W.L. Gore & Associates

W.L. Gore loses bid to toss verdict in stent graft patent loss to C.R. Bard

September 21, 2017 By Fink Densford

A Delaware federal judge this week dismissed an attempt from W.L. Gore & Associates to clear a jury finding from March which ruled that 1 of its stent patents was invalid in an ongoing patent spat with C.R. Bard (NYSE:BCR), Law360 reports. U.S. District Judge Leonard Stark denied 3 motions for judgement, including 2 motions arguing […]

Filed Under: Legal News, Patent Infringement, Stents Tagged With: C.R. Bard, W.L. Gore & Associates

Studies support anti-stroke PFO closure devices from Abbott, Gore

September 15, 2017 By Brad Perriello

A trio of studies published this week in the New England Journal of Medicine showed that devices from Abbott (NYSE:ABT) and W.L. Gore & Assoc. designed to close a heart defect lowered the risk of a recurring episode in certain cryptogenic stroke patients. Long-term results from the 980-patient Respect trial of the Amplatzer device Abbott acquired […]

Filed Under: Cardiovascular, Clinical Trials, Surgical Tagged With: Abbott, Structural heart, W.L. Gore & Associates

Gore touts reduced portal hypertension, complications in Viatorr Tips trial

August 1, 2017 By Fink Densford

W.L. Gore & Associates today released preliminary data from a trial of its Viatorr Tips endoprosthesis with controlled expansion, touting reduced portal hypertension treatment complications when compared to the company’s legacy Tips device and bare metal stents. Data from the study was presented at The International Liver Congress 2017 in Amsterdam, the Flagstaff, Ariz.-based company […]

Filed Under: Blood Management, Clinical Trials, Stent Grafts, Stents, Vascular Tagged With: W.L. Gore & Associates

Gore touts 1st commercial use of Tag thoracic stent graft

July 13, 2017 By Fink Densford

W.L. Gore & Associates said today its Tag conformable thoracic stent graft was used in its 1st commercial procedure after the system won CE Mark approval in the European Union last month. The procedure was performed by Dr. Giovanni Torsello and Dr. Martin Austermann of Munster, Germany’s St. Franziskus Hospital, the Flagstaff, Ariz.-based company said. “The enhanced […]

Filed Under: Business/Financial News, Stent Grafts, Vascular Tagged With: W.L. Gore & Associates

Gore wins FDA nod for Synecor preperitonial hernia repair system

June 7, 2017 By Fink Densford

W.L. Gore & Associates said today it won FDA 510(k) clearance for its Synecor preperitoneal biomaterial hernia repair device, with plans to launch the device this week. The Synecor preperitoneal biomaterial is a hybrid biosynthetic hernia repair device designed for use in single-stage preperitoneal, onlay and retromuscular placements through open, laparoscopic and robotic procedures, the Flagstaff, […]

Filed Under: 510(k), Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: W.L. Gore & Associates

Gore wins Japanese regulatory nod for Gore Excluder IBE

May 24, 2017 By Fink Densford

W.L. Gore & Associates said today it won Japanese regulatory approval for its Gore Excluder iliac branch endoprosthesis and that the 1st implants of the device had been performed in the region. The Newark, Del.-based company said that the Excluder IBE was the 1st off-the-shelf iliac branch solution approved in the country, and the only device […]

Filed Under: Regulatory/Compliance, Stent Grafts, Vascular Tagged With: W.L. Gore & Associates

ViaCyte looks to cell replacement therapy to cure Type I diabetes

May 22, 2017 By Sarah Faulkner

ViaCyte said today that it will begin clinical trials of its novel islet cell replacement therapy in development as a potential cure for Type I diabetes, after landing regulatory wins from the FDA and Health Canada. The company’s PEC-Direct candidate delivers stem cell-derived pancreatic progenitor cells in a device that is designed to enable direct […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Food & Drug Administration (FDA), Funding Roundup, Wall Street Beat Tagged With: Juvenile Diabetes Research Foundation (JDRF), ViaCyte Inc., W.L. Gore & Associates

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS